arXiv subjects

Yibo Li

Publications and source records attributed to Yibo Li.

46 records · Page 3Linked to original sources

arXiv2024

DeepRLI: A Multi-objective Framework for Universal Protein--Ligand Interaction Prediction

Protein (receptor)--ligand interaction prediction is a critical component in computer-aided drug design, significantly influencing molecular docking and virtual screening processes. Despite the development of numerous scoring functions in recent years, particularly those employing machine learning, accurately and efficiently predicting binding affinities for protein--ligand complexes remains a formidable challenge. Most contemporary methods are tailored for specific tasks, such as binding affinity prediction, binding pose prediction, or virtual screening, often failing to encompass all aspects. In this study, we put forward DeepRLI, a novel protein--ligand interaction prediction architecture. It encodes each protein--ligand complex into a fully connected graph, retaining the integrity of the topological and spatial structure, and leverages the improved graph transformer layers with cosine envelope as the central module of the neural network, thus exhibiting superior scoring power. In order to equip the model to generalize to conformations beyond the confines of crystal structures and to adapt to molecular docking and virtual screening tasks, we propose a multi-objective strategy, that is, the model outputs three scores for scoring and ranking, docking, and screening, and the training process optimizes these three objectives simultaneously. For the latter two objectives, we augment the dataset through a docking procedure, incorporate suitable physics-informed blocks and employ an effective contrastive learning approach. Eventually, our model manifests a balanced performance across scoring, ranking, docking, and screening, thereby demonstrating its ability to handle a range of tasks. Overall, this research contributes a multi-objective framework for universal protein--ligand interaction prediction, augmenting the landscape of structure-based drug design.

q-bio.BM↗

arXiv2023

On the maximal Sombor index of quasi-tree graphs

The Sombor index $SO(G)$ of a graph $G$ is the sum of the edge weights $\sqrt{d^2_G(u)+d^2_G(v)}$ of all edges $uv$ of $G$, where $d_G(u)$ denotes the degree of the vertex $u$ in $G$. A connected graph $G = (V ,E)$ is called a quasi-tree, if there exists $u\in V (G)$ such that $G-u$ is a tree. Denote $\mathscr{Q}(n,k)$=\{$G$: $G$ is a quasi-tree graph of order $n$ with $G-u$ being a tree and $d_G(u)=k$\}. In this paper, we determined the maximum, the second maximum and the third maximum Sombor indices of all quasi-tree graphs in $\mathscr{Q}(n,k)$, respectively. Moreover, we characterized their corresponding extremal graphs, respectively.

math.CO↗

arXiv2023

Improving Table Structure Recognition with Visual-Alignment Sequential Coordinate Modeling

Table structure recognition aims to extract the logical and physical structure of unstructured table images into a machine-readable format. The latest end-to-end image-to-text approaches simultaneously predict the two structures by two decoders, where the prediction of the physical structure (the bounding boxes of the cells) is based on the representation of the logical structure. However, the previous methods struggle with imprecise bounding boxes as the logical representation lacks local visual information. To address this issue, we propose an end-to-end sequential modeling framework for table structure recognition called VAST. It contains a novel coordinate sequence decoder triggered by the representation of the non-empty cell from the logical structure decoder. In the coordinate sequence decoder, we model the bounding box coordinates as a language sequence, where the left, top, right and bottom coordinates are decoded sequentially to leverage the inter-coordinate dependency. Furthermore, we propose an auxiliary visual-alignment loss to enforce the logical representation of the non-empty cells to contain more local visual details, which helps produce better cell bounding boxes. Extensive experiments demonstrate that our proposed method can achieve state-of-the-art results in both logical and physical structure recognition. The ablation study also validates that the proposed coordinate sequence decoder and the visual-alignment loss are the keys to the success of our method.

cs.CV↗

arXiv2022

Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers

Finding drug-like compounds with high bioactivity is essential for drug discovery, but the task is complicated by the high cost of chemical synthesis and validation. With their outstanding performance in de novo drug design, deep generative models represent promising tools for tackling this challenge. In recently years, 3D molecule generative models have gained increasing attention due to their ability to directly utilize the 3D interaction information between the target and ligand. However, it remains challenging to synthesize the molecules generated by these models, limiting the speed of bioactivity validation and further structure optimization. In this work, we propose DeepLigBuilder+, a deep generative model for 3D molecules that combines structure-based de novo drug design with a reaction-based generation framework. Besides producing 3D molecular structures, the model also proposes synthetic pathways for generated molecules, which greatly assists the retro-synthetic analysis. To achieve this, we developed a new way to enforce the synthesizability constraint using a tree-based organization of purchasable building blocks. This method enjoys high scalability and is compatible with existing atom-based generative models. Additionally, for structure-based design tasks, we developed an SE(3)-equivariant transformer conditioned on the shape and pharmacophore-based inputs, and combine it with the Monte Carlo tree search. Using the ATP-binding pocket of BTK and the NAD+ binding pocket of PHGDH for case studies, we demonstrate that DeepLigBuilder+ is capable of enriching drug-like molecules with high predicted binding affinity and desirable interaction modes while maintaining the synthesizability constraint. We believe that DeepLigBuilder+ is a powerful tool for accelerating the process of drug discovery.

q-bio.QM↗

arXiv2022

Space4HGNN: A Novel, Modularized and Reproducible Platform to Evaluate Heterogeneous Graph Neural Network

Heterogeneous Graph Neural Network (HGNN) has been successfully employed in various tasks, but we cannot accurately know the importance of different design dimensions of HGNNs due to diverse architectures and applied scenarios. Besides, in the research community of HGNNs, implementing and evaluating various tasks still need much human effort. To mitigate these issues, we first propose a unified framework covering most HGNNs, consisting of three components: heterogeneous linear transformation, heterogeneous graph transformation, and heterogeneous message passing layer. Then we build a platform Space4HGNN by defining a design space for HGNNs based on the unified framework, which offers modularized components, reproducible implementations, and standardized evaluation for HGNNs. Finally, we conduct experiments to analyze the effect of different designs. With the insights found, we distill a condensed design space and verify its effectiveness.

cs.LG↗

arXiv2021

Automatic Description Construction for Math Expression via Topic Relation Graph

Math expressions are important parts of scientific and educational documents, but some of them may be challenging for junior scholars or students to understand. Nevertheless, constructing textual descriptions for math expressions is nontrivial. In this paper, we explore the feasibility to automatically construct descriptions for math expressions. But there are two challenges that need to be addressed: 1) finding relevant documents since a math equation understanding usually requires several topics, but these topics are often explained in different documents. 2) the sparsity of the collected relevant documents making it difficult to extract reasonable descriptions. Different documents mainly focus on different topics which makes model hard to extract salient information and organize them to form a description of math expressions. To address these issues, we propose a hybrid model (MathDes) which contains two important modules: Selector and Summarizer. In the Selector, a Topic Relation Graph (TRG) is proposed to obtain the relevant documents which contain the comprehensive information of math expressions. TRG is a graph built according to the citations between expressions. In the Summarizer, a summarization model under the Integer Linear Programming (ILP) framework is proposed. This module constructs the final description with the help of a timeline that is extracted from TRG. The experimental results demonstrate that our methods are promising for this task and outperform the baselines in all aspects.

cs.IR↗

arXiv2021

Learning to design drug-like molecules in three-dimensional space using deep generative models

Recently, deep generative models for molecular graphs are gaining more and more attention in the field of de novo drug design. A variety of models have been developed to generate topological structures of drug-like molecules, but explorations in generating three-dimensional structures are still limited. Existing methods have either focused on low molecular weight compounds without considering drug-likeness or generate 3D structures indirectly using atom density maps. In this work, we introduce Ligand Neural Network (L-Net), a novel graph generative model for designing drug-like molecules with high-quality 3D structures. L-Net directly outputs the topological and 3D structure of molecules (including hydrogen atoms), without the need for additional atom placement or bond order inference algorithm. The architecture of L-Net is specifically optimized for drug-like molecules, and a set of metrics is assembled to comprehensively evaluate its performance. The results show that L-Net is capable of generating chemically correct, conformationally valid, and highly druglike molecules. Finally, to demonstrate its potential in structure-based molecular design, we combine L-Net with MCTS and test its ability to generate potential inhibitors targeting ABL1 kinase.

q-bio.QM↗

arXiv2020

TF3P: Three-dimensional Force Fields Fingerprint Learned by Deep Capsular Network

Molecular fingerprints are the workhorse in ligand-based drug discovery. In recent years, an increasing number of research papers reported fascinating results on using deep neural networks to learn 2D molecular representations as fingerprints. It is anticipated that the integration of deep learning would also contribute to the prosperity of 3D fingerprints. Here, we unprecedentedly introduce deep learning into 3D small molecule fingerprints, presenting a new one we termed as the three-dimensional force fields fingerprint (TF3P). TF3P is learned by a deep capsular network whose training is in no need of labeled datasets for specific predictive tasks. TF3P can encode the 3D force fields information of molecules and demonstrates the stronger ability to capture 3D structural changes, to recognize molecules alike in 3D but not in 2D, and to identify similar targets inaccessible by other 2D or 3D fingerprints based on only ligands similarity. Furthermore, TF3P is compatible with both statistical models (e.g. similarity ensemble approach) and machine learning models. Altogether, we report TF3P as a new 3D small molecule fingerprint with a promising future in ligand-based drug discovery. All codes are written in Python and available at https://github.com/canisw/tf3p.

q-bio.QM↗

arXiv2019

DeepScaffold: a comprehensive tool for scaffold-based de novo drug discovery using deep learning

The ultimate goal of drug design is to find novel compounds with desirable pharmacological properties. Designing molecules retaining particular scaffolds as the core structures of the molecules is one of the efficient ways to obtain potential drug candidates with desirable properties. We proposed a scaffold-based molecular generative model for scaffold-based drug discovery, which performs molecule generation based on a wide spectrum of scaffold definitions, including BM-scaffolds, cyclic skeletons, as well as scaffolds with specifications on side-chain properties. The model can generalize the learned chemical rules of adding atoms and bonds to a given scaffold. Furthermore, the generated compounds were evaluated by molecular docking in DRD2 targets and the results demonstrated that this approach can be effectively applied to solve several drug design problems, including the generation of compounds containing a given scaffold and de novo drug design of potential drug candidates with specific docking scores. Finally, a command line interface is created.

q-bio.QM↗

arXiv2018

Multi-Objective De Novo Drug Design with Conditional Graph Generative Model

Recently, deep generative models have revealed itself as a promising way of performing de novo molecule design. However, previous research has focused mainly on generating SMILES strings instead of molecular graphs. Although current graph generative models are available, they are often too general and computationally expensive, which restricts their application to molecules with small sizes. In this work, a new de novo molecular design framework is proposed based on a type sequential graph generators that do not use atom level recurrent units. Compared with previous graph generative models, the proposed method is much more tuned for molecule generation and have been scaled up to cover significantly larger molecules in the ChEMBL database. It is shown that the graph-based model outperforms SMILES based models in a variety of metrics, especially in the rate of valid outputs. For the application of drug design tasks, conditional graph generative model is employed. This method offers higher flexibility compared to previous fine-tuning based approach and is suitable for generation based on multiple objectives. This approach is applied to solve several drug design problems, including the generation of compounds containing a given scaffold, generation of compounds with specific drug-likeness and synthetic accessibility requirements, as well as generating dual inhibitors against JNK3 and GSK3$β$. Results show high enrichment rates for outputs satisfying the given requirements.

q-bio.QM↗